Skip to main content
Erschienen in: The European Journal of Health Economics 3/2005

01.09.2005 | Original Papers

Measuring health-related utility:

Why the disparity between EQ-5D and SF-6D?

verfasst von: Stirling Bryan, Louise Longworth

Erschienen in: The European Journal of Health Economics | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

There remains considerable disagreement concerning the preferred generic utility-based measure of health-related quality of life for use in constructing quality-adjusted life years. The recent appearance (in a published form) of a new measure, the SF-6D, has highlighted this issue. The SF-6D and EQ-5D have many similarities, but marked variation has been shown in the results generated by the two instruments. The study reported here is an exploration of why such divergent results exist. There are two possible explanations: variation in the descriptive component of the instruments and variation in the values applied to health states. The results suggest two important conclusions. First, the SF-6D can describe severe health states, including states that (according to the EQ-5D scoring algorithm) are viewed as worse than the state of being ‘dead’. Second, much of the large discrepancy between the results generated using the two instruments appears to stem from very different valuations being placed on similar health states.
Literatur
1.
Zurück zum Zitat Bosch J, Hunink M (2000) Comparison of the Health Utilities Index mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res 9:591–601CrossRefPubMed Bosch J, Hunink M (2000) Comparison of the Health Utilities Index mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res 9:591–601CrossRefPubMed
2.
Zurück zum Zitat Brazier J, Deverill M, Green C, Harper R, Booth A (1999) A review of the use of health status measures in economic evaluation. Health Technol Assess 3 (9) Brazier J, Deverill M, Green C, Harper R, Booth A (1999) A review of the use of health status measures in economic evaluation. Health Technol Assess 3 (9)
3.
Zurück zum Zitat Brazier J, Roberts J, Tsuchiya A, Busschbach J (2001) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884CrossRef Brazier J, Roberts J, Tsuchiya A, Busschbach J (2001) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884CrossRef
4.
Zurück zum Zitat Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292PubMed Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271–292PubMed
5.
Zurück zum Zitat Coons S, Rao S, Keininger D, Hays R (2000) A comparative review of generic quality of life instruments. Pharmacoeconomics 17:13–35PubMed Coons S, Rao S, Keininger D, Hays R (2000) A comparative review of generic quality of life instruments. Pharmacoeconomics 17:13–35PubMed
6.
Zurück zum Zitat Dolan P (1997) Modelling valuations for EuroQol health states. Med Care 35:1095–1108PubMed Dolan P (1997) Modelling valuations for EuroQol health states. Med Care 35:1095–1108PubMed
7.
Zurück zum Zitat Dolan P, Sutton M (1997) Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med 10:1519–1530CrossRef Dolan P, Sutton M (1997) Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med 10:1519–1530CrossRef
8.
Zurück zum Zitat Elvik R (1995) The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med 40:1385–1398 Elvik R (1995) The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med 40:1385–1398
9.
Zurück zum Zitat Glick H, Polsky D, Willke R, Schulman K (1999) A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making 19:265–274PubMed Glick H, Polsky D, Willke R, Schulman K (1999) A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making 19:265–274PubMed
10.
Zurück zum Zitat Haan R de, Aaronson N, Limberg M, Langton R, van Crevel H (1993) Measuring quality of life in stroke. Stroke 24:320–327PubMed Haan R de, Aaronson N, Limberg M, Langton R, van Crevel H (1993) Measuring quality of life in stroke. Stroke 24:320–327PubMed
11.
Zurück zum Zitat Hawthorne G, Richardson J, Day NA (2001) A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Intern Med 33:358–370 Hawthorne G, Richardson J, Day NA (2001) A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Intern Med 33:358–370
12.
Zurück zum Zitat Hill SR, Mitchell AS, Henry DA (2000) Problems with the interpretation of pharmacoeconomic analyses. JAMA 283:2116–2121CrossRefPubMed Hill SR, Mitchell AS, Henry DA (2000) Problems with the interpretation of pharmacoeconomic analyses. JAMA 283:2116–2121CrossRefPubMed
13.
Zurück zum Zitat Holland R, Smith RD, Harvey I, Swift L, Lenaghan E (2004) Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ 13:793–805CrossRefPubMed Holland R, Smith RD, Harvey I, Swift L, Lenaghan E (2004) Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ 13:793–805CrossRefPubMed
14.
Zurück zum Zitat Hollingworth W, Mackenzie R, Todd CJ, Dixon AK (1995) Measuring changes in quality of life following magnetic resonance imaging of the knee: SF-36, EuroQol or Rosser Index? Qual Life Res 4:325–334CrossRefPubMed Hollingworth W, Mackenzie R, Todd CJ, Dixon AK (1995) Measuring changes in quality of life following magnetic resonance imaging of the knee: SF-36, EuroQol or Rosser Index? Qual Life Res 4:325–334CrossRefPubMed
15.
Zurück zum Zitat Longworth L, Bryan S (2003) An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 12:1061–1067PubMed Longworth L, Bryan S (2003) An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 12:1061–1067PubMed
16.
Zurück zum Zitat Longworth L, Ratcliffe J, Young T, Bryan S (2001) A comparison of the EQ-5D and SF-6D single index in assessing the health-related quality of life of liver transplant patients. Proceedings of the 18th Plenary Meeting of the EuroQol Group Longworth L, Ratcliffe J, Young T, Bryan S (2001) A comparison of the EQ-5D and SF-6D single index in assessing the health-related quality of life of liver transplant patients. Proceedings of the 18th Plenary Meeting of the EuroQol Group
17.
Zurück zum Zitat Longworth L, Young T, Ratcliffe J, Bryan S, Buxton M (2001) The cost-effectiveness of liver transplantation for three disease categories. Report for the Department of Health Longworth L, Young T, Ratcliffe J, Bryan S, Buxton M (2001) The cost-effectiveness of liver transplantation for three disease categories. Report for the Department of Health
18.
Zurück zum Zitat Lubetkin E, Gold M (2001) Areas of decrement in health-related quality of life in a health center population, Proceedings of the 18th Plenary Meeting of the EuroQol Group, pp 149–160 Lubetkin E, Gold M (2001) Areas of decrement in health-related quality of life in a health center population, Proceedings of the 18th Plenary Meeting of the EuroQol Group, pp 149–160
19.
Zurück zum Zitat Nord E, Richardson J, Macarounas-Kirchmann K (1993) Social evaluation of health care versus personal evaluation of health states: evidence on the validity of four health—state scaling instruments using Norwegian and Australian Surveys. Int J Technol Assess Health Care 9:463–478 Nord E, Richardson J, Macarounas-Kirchmann K (1993) Social evaluation of health care versus personal evaluation of health states: evidence on the validity of four health—state scaling instruments using Norwegian and Australian Surveys. Int J Technol Assess Health Care 9:463–478
20.
Zurück zum Zitat O’Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier P (2003) A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 12:975–981PubMed O’Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier P (2003) A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 12:975–981PubMed
21.
Zurück zum Zitat Raftery J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 323:1300–1303CrossRefPubMed Raftery J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 323:1300–1303CrossRefPubMed
22.
Zurück zum Zitat Ratcliffe J, Longworth L, Young T, Burroughs A, Buxton M, on behalf of the Cost-effectiveness of Liver Transplantation Study Team (CELT) (2002) Assessing health related quality of life pre and post liver transplantation: a prospective multi-centre study. Liver Transpl 8:263–270CrossRefPubMed Ratcliffe J, Longworth L, Young T, Burroughs A, Buxton M, on behalf of the Cost-effectiveness of Liver Transplantation Study Team (CELT) (2002) Assessing health related quality of life pre and post liver transplantation: a prospective multi-centre study. Liver Transpl 8:263–270CrossRefPubMed
23.
Zurück zum Zitat Schulz M, Chen J, Woo H, Keech M, Watson M, Davey P (2002) A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. J Urol 168:155–159CrossRefPubMed Schulz M, Chen J, Woo H, Keech M, Watson M, Davey P (2002) A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia. J Urol 168:155–159CrossRefPubMed
24.
Zurück zum Zitat Spady B, Suarez-Almazor M (2001) A comparison of preference-based health status tools in patients with musculoskeletal disease. Proceedings of the 18th Plenary Meeting of the EuroQol Group, pp 235–243 Spady B, Suarez-Almazor M (2001) A comparison of preference-based health status tools in patients with musculoskeletal disease. Proceedings of the 18th Plenary Meeting of the EuroQol Group, pp 235–243
25.
Zurück zum Zitat Stavem K, Bjornaes H, Lossius M (2001) Properties of the 15D and EQ-5D Utility measures in a community sample of people with epilepsy. Epilepsy Res 44:179–189PubMed Stavem K, Bjornaes H, Lossius M (2001) Properties of the 15D and EQ-5D Utility measures in a community sample of people with epilepsy. Epilepsy Res 44:179–189PubMed
26.
Zurück zum Zitat Suarez-Almazor M, Kendall C, Johnson, Skeith K, Vincent D (2000) Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxf) 39:783–790 Suarez-Almazor M, Kendall C, Johnson, Skeith K, Vincent D (2000) Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments. Rheumatology (Oxf) 39:783–790
27.
Zurück zum Zitat Torrance G, Furlong W, Feeny D (2002) Health utility estimation. Expert Rev Pharmacoecon Outcomes Res 2:99–108CrossRef Torrance G, Furlong W, Feeny D (2002) Health utility estimation. Expert Rev Pharmacoecon Outcomes Res 2:99–108CrossRef
28.
Zurück zum Zitat Tosteson A, Hammond C (2002) Quality of life assessment in osteoporosis. Pharmacoeconomics 20:289–303PubMed Tosteson A, Hammond C (2002) Quality of life assessment in osteoporosis. Pharmacoeconomics 20:289–303PubMed
Metadaten
Titel
Measuring health-related utility:
Why the disparity between EQ-5D and SF-6D?
verfasst von
Stirling Bryan
Louise Longworth
Publikationsdatum
01.09.2005
Verlag
Springer-Verlag
Erschienen in
The European Journal of Health Economics / Ausgabe 3/2005
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-005-0299-9

Weitere Artikel der Ausgabe 3/2005

The European Journal of Health Economics 3/2005 Zur Ausgabe